Company profile
Amplia Therapeutics Limited
Amplifying Oncology Treatments
- Industry
- Pharmaceutical Manufacturing
- Employees
- 13
- Headquarters
- Melbourne, Victoria
- Founded
- 2016
- LinkedIn followers
- 2,813
- Office locations
- 1
Amplia Therapeutics Limited company summary
Amplia Therapeutics Limited is a company in the Pharmaceutical Manufacturing industry, headquartered in Melbourne, Victoria, founded in 2016. On LinkedIn the company has around 13 employees and 2,813 followers.
What technology does Amplia Therapeutics Limited use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Amplia Therapeutics Limited
Amplia Therapeutics Limited (ASX: ATX; OTCQB: INNMF), a pharmaceutical company based in Melbourne, Australia, focuses on development of focal adhesion kinase (FAK) inhibitors for the treatment of cancer and chronic fibrotic diseases. The company's lead product is narmafotinib (AMP945), a best-in-class inhibitor of FAK, currently undergoing clinical trials in advanced pancreatic cancer. Data from the Phase 1b/2a ACCENT trial run in Australia and Korea has been very positive and a new clinical trial is now opening in the US and Australia under an open IND. Additional opportunities in other cancers such as ovarian cancer, and in fibrotic diseases such as idiopathic pulmonary fibrosis, are also being explored based on promising preclinical data. Narmafotinib has Orphan Drug Designation and Fast-Track Designation from the US FDA for pancreatic cancer.
Where is Amplia Therapeutics Limited located?
Amplia Therapeutics Limited lists 1 location.
Compare companies similar to Amplia Therapeutics Limited
More companies in Pharmaceutical Manufacturing.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Amplia Therapeutics Limited ampliatx.com | Pharmaceutical Manufacturing | 13 | 2016 | Melbourne, Victoria |
 Anacor Pharmaceuticals pfizer.com | Pharmaceutical Manufacturing | 108,102 | - | New York, New York |
 Sanofi sanofi.com | Pharmaceutical Manufacturing | 93,352 | - | Paris, France, FR |
 GSK gsk.com | Pharmaceutical Manufacturing | 92,179 | - | London, England |
 Novartis España novartis.com | Pharmaceutical Manufacturing | 85,373 | - | Basel, Baselstadt |
 AstraZeneca astrazeneca.com | Pharmaceutical Manufacturing | 80,667 | - | Cambridge, Cambridgeshire, GB |
 Eli Lilly and Company lilly.com | Pharmaceutical Manufacturing | 57,202 | - | Indianapolis, Indiana |
 Merck merck.us | Pharmaceutical Manufacturing | 44,794 | - | Rahway, New Jersey |
 SUN PHARMA sunpharma.com | Pharmaceutical Manufacturing | 47,764 | 1983 | Mumbai, Maharastra |
 Boehringer Ingelheim boehringer-ingelheim.com | Pharmaceutical Manufacturing | 47,150 | - | Ingelheim am Rhein, Rhineland-Palatinate |
 Cipla cipla.com | Pharmaceutical Manufacturing | 51,911 | - | Mumbai, Maharashtra |
Frequently asked questions about Amplia Therapeutics Limited
What does Amplia Therapeutics Limited do?
Amplia Therapeutics Limited (ASX: ATX; OTCQB: INNMF), a pharmaceutical company based in Melbourne, Australia, focuses on development of focal adhesion kinase (FAK) inhibitors for the treatment of cancer and chronic fibrotic diseases. The company's lead product is narmafotinib (AMP945), a best-in-class inhibitor of FAK, currently undergoing clinical trials in advanced pancreatic cancer. Data from the Phase 1b/2a ACCENT trial run in Australia and Korea has been very positive and a new clinical trial is now opening in the US and Australia under an open IND. Additional opportunities in other cancers such as ovarian cancer, and in fibrotic diseases such as idiopathic pulmonary fibrosis, are also being explored based on promising preclinical data. Narmafotinib has Orphan Drug Designation and Fast-Track Designation from the US FDA for pancreatic cancer.
How many employees does Amplia Therapeutics Limited have?
Amplia Therapeutics Limited has around 13 employees on LinkedIn.
Where is Amplia Therapeutics Limited headquartered?
Amplia Therapeutics Limited is headquartered in Melbourne, Victoria.
When was Amplia Therapeutics Limited founded?
Amplia Therapeutics Limited was founded in 2016.
Build a lead list from companies like Amplia Therapeutics Limited
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.